While CD44+ CD51– TNCs also expanded 14 days after 5FU treatments in p32−/− bone marrow (Figure S4E), while severe anemia was observed in the peripheral blood (Figures 1D–1F), suggesting p32-deficiency blocks erythroid differentiation of CD44+ CD51– TNCs. The gene discussed is C1QBP; the disease is anemia.